Bertrand Pain Team Leader / DR2
Our work aims to decipher cellular and molecular mechanisms controlling the establishment and the maintenance of pluripotency in several species including porcine, bovine and caprine but also Aves as a model of non-mammalian species and to compare them with those of the canonical mouse model, taken as the reference in the stem cell field. For this purpose, our research is based on three complementary axes.
Axis 1: Derivation and characterization of avian embryonic stem cells:
We were pioneers in the isolation, in vitro establishment and characterization of chicken embryonic stem cells (ESC) (Pain et al, 1996). These cells have been shown to be pluripotent since they display self-renewal and differentiation properties and contribute to chimera when they are re-injected into pregastrulatring embryos (Lavial et al., 2007). This long term establishment is achieved using various culture media, which leads to different pluripotent stem cells that are then characterized at the molecular, epigenetic and developmental levels (Kress et al., 2016). Primordial germ cells (PGC), which are closely related to ESCs but specified differently in avian species compared to mammalian ones, are also isolated, in vitro grown in long term cultures and analysed. Ongoing research is focused on the development of new tools based of fluorescent reporter genes to label and enrich cellular populations according to specific pluripotent states. Their developmental properties and their colonization potential are then investigated.
Axis2: Derivation of induced pluripotent stem cells from various mammalian species:
It has also been shown that somatic cells can be converted into pluripotent cells (iPSCs) by over-expressing 3 or 4 specific exogenous factors (Sox2, Oct4, Klf4 ± c-Myc). By using this “Yamanaka” cocktail combined with other factors, we derive new induced pluripotent stem (iPS) cell types from various mammalian rent animals (pig, sheep, goat, bovine, horse, etc…) or from more exotic ones such as bats and avian species (chicken, quail, duck). The recent mastering of the somatic reprogramming in avian species (Fuet et al., submitted) as well as the well-mastered approach in mammals, including the identification of new gene combinations (Jean et al., 2017, EP17305082.4, patent) opens the way to generate new cell types. Those different iPS cell types are characterized by immunochemistry (cell markers) and biochemistry (alkaline phosphatase and telomerase activity) and compared with the starting primary cells as well as with the early embryos by RNAseq and ChipSeq. All together those data provide a comparison basis for establishing the pluripotent networks in all those species with a phylogenetic perspective.
Axis3: Biotechnology of pluripotent cells:
Pluripotent stem cells are a unique source of cell plasticity to generate specific derivatives by controlling their differentiation process. By applying various protocols of differentiation to engage the pluripotent stem cells toward different lineages, a large spectrum of differentiated progenitors were able to be produced (Vautherot et al., 2013, N° FR1357346, patent, Couteaudier et al., 2015; Vautherot et al., 2017). Beside the fundamental research, for which obtaining and characterizing specific differentiated cells from pluripotent stem cells are a real challenge, one of the main interest of those pluripotent and iPS cells lies in their biotechnological potential. In particular, these cells and their differentiated derivatives are useful cellular substrates for viral and bacterial studies as well as vaccine production. Some of them are already used in industrial development and other are either under validation or developmental processes.
|2013||55(1):41-51||Pluripotent genes in avian stem cells||Jean C, Aubel P, Soleihavoup C, Bouhallier F, Voisin S, Lavial F, Pain B||Dev Growth Differ||-|
|2015||83(3):377-84||Identification of side population cells in chicken embryonic gonads||Bachelard E, Raucci F, Montillet G, Pain B||Theriogenology||-|
|2015||84(5):732-42.e1-2||In vitro generation and characterization of chicken long-term germ cells from different embryonic origins||Raucci F, Fuet A, Pain B||Theriogenology||-|
|2015||6:7095||Reinforcement of STAT3 activity reprogrammes human embryonic stem cells to naive-like pluripotency||Chen H, Aksoy I, Gonnot F, Osteil P, Aubry M, Hamela C, Rognard C, Hochard A, Voisin S, Fontaine E, Mure M, Afanassieff M, Cleroux E, Guibert S, Chen J, Vallot C, Acloque H, Genthon C, Donnadieu C, De Vos J, Sanlaville D, Guérin JF, Weber M, Stanton LW, Rougeulle C, Pain B, Bourillot PY, Savatier P||Nat Commun||-|
|2015||14(2):224-37||Derivation of keratinocytes from chicken embryonic stem cells: establishment and characterization of differentiated proliferative cell populations||Couteaudier M, Trapp-Fragnet L, Auger N, Courvoisier K, Pain B, Denesvre C, Vautherot JF||Stem Cell Res||-|
|2015||14(1):54-67||Transcriptome analysis of chicken ES, blastodermal and germ cells reveals that chick ES cells are equivalent to mouse ES cells rather than EpiSC||Jean C, Oliveira NM, Intarapat S, Fuet A, Mazoyer C, De Almeida I, Trevers K, Boast S, Aubel P, Bertocchini F, Stern CD, Pain B||Stem Cell Res||-|
|2016||09:05||Chicken embryonic stem cells and primordial germ cells display different heterochromatic histone marks than their mammalian counterparts||Kress C, Montillet G, Jean C, Fuet A, Pain B||Epigenetics Chromatin||-|
|2018||13;11(5):1272-1286||NANOG Is Required for the Long-Term Establishment of Avian Somatic Reprogrammed Cells||Fuet A, Montillet G, Jean C, Aubel P, Kress C, Rival-Gervier S, Pain B||Stem Cell Reports||-|
|2018||13(9):e0200515||Three-dimensional culture of chicken primordial germ cells (cPGCs) in defined media containing the functional polymer FP003||Chen YC, Chang WC, Lin SP, Minami M, Jean C, Hayashi H, Rival-Gervier S, Kanaki T, Wu SC, Pain B||PLoS One||-|
|2018||19;19(1):480||Correction to: Stage-dependent piRNAs in chicken implicated roles in modulating male germ cell development||Chang KW, Tseng YT, Chen YC, Yu CY, Liao HF, Chen YC, Tu YE, Wu SC, Liu IH, Pinskaya M, Morillon A, Pain B, Lin SP||BMC Genomics||-|